Sequent Scientific Limited (SEQUENT.BO)
INR 181.65
(-0.6%)
INR 181.65
(-0.6%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.42 Billion INR | -35.06% |
| 2022 | 2.19 Billion INR | 33.76% |
| 2021 | 1.64 Billion INR | 18.12% |
| 2020 | 1.39 Billion INR | -31.64% |
| 2019 | 2.03 Billion INR | 33.59% |
| 2018 | 1.52 Billion INR | 38.69% |
| 2017 | 1.09 Billion INR | -33.95% |
| 2016 | 1.66 Billion INR | -21.32% |
| 2015 | 2.11 Billion INR | -14.47% |
| 2014 | 2.47 Billion INR | 63.54% |
| 2013 | 1.51 Billion INR | 9.45% |
| 2012 | 1.38 Billion INR | 70.28% |
| 2011 | 810.65 Million INR | -18.27% |
| 2010 | 991.92 Million INR | -43.36% |
| 2009 | 1.75 Billion INR | 80.54% |
| 2008 | 969.93 Million INR | 284.79% |
| 2007 | 252.06 Million INR | 477.67% |
| 2006 | 43.63 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | 1.85 Billion INR | 0.0% |
| 2023 Q4 | 1.42 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 1.42 Billion INR | -35.06% |
| 2022 FY | 2.19 Billion INR | 33.76% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 1.91 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 2.19 Billion INR | 0.0% |
| 2021 Q2 | 1.27 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 1.64 Billion INR | 18.12% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.64 Billion INR | 0.0% |
| 2020 Q4 | 1.39 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 1.39 Billion INR | -31.64% |
| 2020 Q2 | 1.29 Billion INR | 0.0% |
| 2019 FY | 2.03 Billion INR | 33.59% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 2.03 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 1.58 Billion INR | 0.0% |
| 2018 Q4 | 1.52 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 1.52 Billion INR | 38.69% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 999.35 Million INR | 0.0% |
| 2017 Q2 | 1.57 Billion INR | 0.0% |
| 2017 FY | 1.09 Billion INR | -33.95% |
| 2017 Q4 | 1.09 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 FY | 1.66 Billion INR | -21.32% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 3.03 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 1.66 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 2.11 Billion INR | 0.0% |
| 2015 Q2 | 2.12 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 2.11 Billion INR | -14.47% |
| 2014 FY | 2.47 Billion INR | 63.54% |
| 2014 Q2 | 1.44 Billion INR | 0.0% |
| 2014 Q4 | 2.47 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 FY | 1.51 Billion INR | 9.45% |
| 2013 Q4 | 1.51 Billion INR | 0.0% |
| 2012 Q2 | 1.94 Billion INR | 0.0% |
| 2012 Q4 | 1.38 Billion INR | 0.0% |
| 2012 FY | 1.38 Billion INR | 70.28% |
| 2011 FY | 810.65 Million INR | -18.27% |
| 2010 FY | 991.92 Million INR | -43.36% |
| 2009 FY | 1.75 Billion INR | 80.54% |
| 2008 FY | 969.93 Million INR | 284.79% |
| 2007 FY | 252.06 Million INR | 477.67% |
| 2006 FY | 43.63 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 235.2 Million INR | -506.798% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -10117.569% |
| Sigachi Industries Limited | 265.79 Million INR | -436.945% |
| Bal Pharma Limited | 363.82 Million INR | -292.275% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -1178.546% |
| Medico Remedies Limited | 8.67 Million INR | -16357.449% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Venus Remedies Limited | 386.8 Million INR | -268.974% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -1238.827% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -1.718% |
| Shilpa Medicare Limited | 5.6 Billion INR | 74.522% |
| Aarti Drugs Limited | 2.75 Billion INR | 48.164% |
| Lupin Limited | 1.55 Billion INR | 8.089% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 93.315% |
| Zydus Lifesciences Limited | 251 Million INR | -468.602% |
| Windlas Biotech Limited | 20.18 Million INR | -6972.299% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Eris Lifesciences Limited | 6.54 Billion INR | 78.194% |
| Valiant Laboratories Limited | 746.63 Million INR | -91.151% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -503.718% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | -34.857% |
| Ipca Laboratories Limited | 5.8 Billion INR | 75.411% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -300.984% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -10630.752% |
| Bajaj HealthCare Limited | 650.34 Million INR | -119.451% |
| RPG Life Sciences Limited | -30.3 Million INR | 4810.198% |
| Mankind Pharma Limited | 248.67 Million INR | -473.913% |
| Laurus Labs Limited | 8.6 Billion INR | 83.412% |
| Piramal Pharma Limited | 24.83 Billion INR | 94.254% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 117178.753% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 91.102% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -126.97% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 5.915% |
| Unichem Laboratories Limited | 382.22 Million INR | -273.394% |
| Novartis India Limited | 50.7 Million INR | -2714.97% |
| Wanbury Limited | 820 Million INR | -74.048% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -572.074% |
| Wockhardt Limited | 8.91 Billion INR | 83.982% |
| Themis Medicare Limited | 267.74 Million INR | -433.051% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -1788.567% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 95.494% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -866.865% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 76.174% |
| Divi's Laboratories Limited | 20 Million INR | -7035.95% |
| NATCO Pharma Limited | 53 Million INR | -2592.811% |
| Gufic Biosciences Limited | 1.53 Billion INR | 7.303% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 85.862% |
| Procter & Gamble Health Limited | 68.8 Million INR | -1974.404% |
| FDC Limited | 2.46 Million INR | -57774.696% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 22.224% |
| Granules India Limited | 689.71 Million INR | -106.926% |
| Medicamen Biotech Limited | 12.55 Million INR | -11267.503% |
| Alkem Laboratories Limited | 400 Million INR | -256.798% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -5027.138% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -39933.38% |
| Megasoft Limited | 1.35 Billion INR | -5.167% |
| ZIM Laboratories Limited | 356 Million INR | -300.889% |
| Strides Pharma Science Limited | 6.71 Billion INR | 78.746% |
| Neuland Laboratories Limited | 449.2 Million INR | -217.714% |
| Morepen Laboratories Limited | 33.64 Million INR | -4142.539% |
| Hikal Limited | 4.22 Billion INR | 66.248% |
| Indoco Remedies Limited | 3.51 Billion INR | 59.424% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -356697.5% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -968.728% |
| Hester Biosciences Limited | 1.81 Billion INR | 21.485% |